PhD, Communication Sciences & Disorders, University of South Florida, 2014
AuD, Audiology, University of South Florida, 2011
BA, Interdisciplinary Sciences, University of California, Santa Barbara, 2007
Interdisciplinary and Emerging Signature Programs
Allergy, Immunology & Infectious Disease
Biomedical Engineering & Nanomedicine
Neurodegenerative Disease
Neuroscience
Other
Research Interests
Dr. Vicky Sanchez is a clinician-scientist in the Department of Otolaryngology. She provides clinical services and leads research studies in the Auditory Rehabilitation & Clinical Trials Laboratory (ARCT Lab). The ARCT Lab is both federally and industry funded, and is a collaborative multi-investigator interprofessional lab. Vicky's research areas of interest are speech perception, auditory rehabilitation, evidence-based practice, and the effects of various disorders and interventions on the auditory and vestibular systems. Vicky's current projects include developing and evaluating novel approaches to treat acquired forms of hearing loss by taking a translational pathway from bench to bedside. Vicky has a strong background in clinical trial administration and sponsored research coordination, in addition to her clinical and research expertise in audiology.
Memberships
Fellow (American Academy of Audiology, 2013 - Present)
Member (Association for Research in Otolaryngology, 2013 - Present)
Member (American Speech-Language Hearing Association (ASAH), 2011 - Present)
Recent Publications
Sanchez VA, Arnold ML, Reed NS, Oree PH, Matthews CR, Clock Eddins A, Lin FR, Chisolm TH. The Hearing Intervention for the Aging and Cognitive Health Evaluation in Elders Randomized Control Trial: Manualization and Feasibility Study.Ear and hearing. 41(5) : 1333-1348
Zhang X, Trendowski MR, Wilkinson E, Shahbazi M, Dinh PC, Shuey MM, Feldman DR, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Huddart R, Martin NE, Sanchez VA, Frisina RD, Einhorn LH, Cox NJ, Travis LB, Dolan ME. Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.Cancer medicine. , 2022.
Arnold ML, Dhar S, Lee DJ, Perreira KM, Pupo D, Tsalatsanis A, Sanchez VA. Sex-Specific Prevalence, Demographic Characteristics, and Risk Factors of Tinnitus in the Hispanic Community Health Study/Study of Latinos.American journal of audiology. 31(1) : 78-90, 2022.
Arnold ML, Haley W, Lin FR, Faucette S, Sherry L, Higuchi K, Witherell K, Anderson E, Reed NS, Chisolm TH, Sanchez VA. Development, assessment, and monitoring of audiologic treatment fidelity in the aging and cognitive health evaluation in elders (ACHIEVE) randomised controlled trial.International journal of audiology. : 1-11, 2021.
Molina JL, Joshi YB, Nungaray JA, Thomas ML, Sprock J, Clayson PE, Sanchez VA, Attarha M, Biagianti B, Swerdlow NR, Light GA. Central auditory processing deficits in schizophrenia: Effects of auditory-based cognitive training.Schizophrenia research. 236: 135-141, 2021.
Arnold ML, Reichard A, Gutman K, Westermann L, Sanchez V. Cross-Cultural Adaptation of Hearing Loss Self-Management Patient Education Materials: Development of the Caja de Instrumentos de Pérdida Auditiva.American journal of audiology. 29(4) : 691-700, 2020.
Wilson RH, Sanchez VA. Effects of the Carrier Phrase on Word Recognition Performances by Younger and Older Listeners Using Two Stimulus Paradigms.Journal of the American Academy of Audiology. 31(6) : 412-441, 2020.
Arnold ML, Oree P, Sanchez V, Reed N, Chisolm T. Development and Formative Assessment of the Hearing Loss Toolkit for Self-Management.Seminars in hearing. 40(1) : 49-67, 2019.
Saunders GH, Frederick MT, Silverman SC, Penman T, Gardner A, Chisolm TH, Escabi CD, Oree PH, Westermann LC, Sanchez VA, Arnold ML. Hearing Screening in the Community.Journal of the American Academy of Audiology. 30(2) : 145-152, 2019.
Deal JA, Goman AM, Albert MS, Arnold ML, Burgard S, Chisolm T, Couper D, Glynn NW, Gmelin T, Hayden KM, Mosley T, Pankow JS, Reed N, Sanchez VA, Richey Sharrett A, Thomas SD, Coresh J, Lin FR. Hearing treatment for reducing cognitive decline: Design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trial.Alzheimer''s & dementia (New York, N. Y.). 4: 499-507, 2018.
